Skip to main content
Cureus logoLink to Cureus
. 2024 Feb 3;16(2):e53484. doi: 10.7759/cureus.53484

Miswak-Infused Glass Ionomer Cement: A Comparative In Vitro Analysis of Antibacterial Efficacy and Compressive Strength

Kamala Devi 1, Jessy Paulraj 1,, Rajeshkumar Shanmugam 2, Subhabrata Maiti 3
Editors: Alexander Muacevic, John R Adler
PMCID: PMC10910250  PMID: 38440002

Abstract

Background: Glass ionomer cement (GIC) restorations are commonly used in primary dentition, due to their aesthetic appeal, self-adhesive nature, and biocompatibility. However, the material's limited antibacterial activity and inadequate mechanical strength highlight the necessity for modifying the material.

Aim: The study aims to evaluate and compare the antimicrobial potency and compressive strength of GIC-incorporated Miswak extract with that of conventional GIC.

Materials and methods: After obtaining the Miswak extract, a modified GIC was formulated by combining the extract with the conventional GIC powder and liquid components, in three different ratios (Powder: Extract and Liquid), Group I (2:1:1), Group II (3:1:2), Group III (3:2:1), and the Group IV as control, which consist of unmodified/conventional GIC. To evaluate and compare the antibacterial efficacy of the modified and unmodified GIC, standard strains of Streptococcus mutans and Lactobacillus were utilized. For each group, the minimal inhibitory concentration (MIC) assay was tested. For the evaluation of compressive strength, cylindrical moulds were utilized in compliance with ISO 9917-1:2007 standards and tested using the universal testing machine (Instron, ElectroPuls®, Bangalore, IND). The highest force exerted at the point of specimen fracture was recorded to calculate the compressive strength values in MPa. The data obtained were analyzed using the Statistical Package for the Social Sciences (IBM SPSS Statistics for Windows, IBM Corp., Version 24.0, Armonk, NY) software. The statistical analysis was conducted utilizing repeated measures of analysis of variance (ANOVA) to calculate the mean MIC values and compressive strength, with pairwise comparisons assessed using Tukey's post hoc test.

Results: The results proved that the antimicrobial properties of Miswak containing GIC performed better against S. mutans and Lactobacillus with a statistically significant difference when compared with group IV (p<0.05), it has been found that an increase in the concentration of extract increased the antimicrobial potency. Significant results were obtained in compressive strength where Group II (41.49±3.6) and Group III (15.23±4.96) proved to be weaker than the control (62.69±2.58), while Group I showed no differences from the control group (p>0.05).

Conclusion: It can be concluded that Group I was found to be better in terms of both antimicrobial properties and compressive strength, where no significant difference in compressive strength was identified when comparing Group I with Group IV. Thus, the overall study depicts that a lesser concentration of extract can be the best option in terms of good antimicrobial properties without altering its strength. Hence, the Miswak containing GIC could be a promising restorative material; further studies should include considering intraoral variables such as masticatory stress, moisture levels and in-vivo tests of this combination.

Keywords: compressive strength, restorative material, modified gic, antimicrobial, miswak

Introduction

Glass ionomer cement (GIC) materials have a five-decade history in clinical applications. Over time, these materials have undergone modifications to serve various purposes, including lining, bonding, sealing, repairing, and restoring teeth. Although GIC is recognized for its features like fluoride release, tooth colour matching, and adhesion to dental structures, it has drawbacks including sensitivity to moisture, limited antimicrobial activity, prolonged wear problems, and inadequate strength, which may impede its effectiveness [1]. Hence, in situations such as insufficient remaining tooth structure to support material or the inability to withstand heavy occlusal loads, which affect the prognosis, GIC is strictly not recommended. The past decades have shown that the use of these materials is expanding; however, they may hold specific niches of clinical use. Caries is a complex and ever-changing dental condition that arises from a combination of factors, including the presence of biofilm, sugar consumption, and the continuous processes of demineralization and remineralization in hard tooth tissue [2]. Dental decay affects both primary and permanent teeth, regardless of age. The initial process involves enamel demineralization, followed by pulp weakening, ultimately resulting in the loss of crown structure. The balance of protective and pathological factors influences the development and progression of caries [3].

Recurrent caries is the most common reason for replacing restorations of all kinds in general dental practice. Prevention of recurrent lesions by using fluoride-releasing restorative materials has been successful. Because recurrent carious lesions are localized and limited, alternative treatments to restorations such as crowns have been proposed, but this is not practical in all cases [4]. It is not advised to intentionally lose tooth structure. Failure to establish a complete seal in the restored tooth enables the persistence of cariogenic bacteria, leading to the recurrence of caries and ultimately resulting in restoration failure [5]. In the case of a minimally interventional approach (ART) to treat caries, recurrent caries have been reported more as cariogenic bacteria get trapped beneath GIC restorations due to manual removal of demineralized tooth tissue using hand instruments. Studies have shown that ART restoration rarely fails after six years due to the development of secondary caries. Hence, an effective way to tackle this challenge is by improving restorative materials that can offer strong hermetic seals and exhibit superior antimicrobial capabilities. Consequently, combining antibacterial agents with GIC might provide a therapeutic benefit. Nevertheless, it's important to note that the inclusion of antimicrobial agents in restorative materials often has an adverse impact on the physical and chemical properties of these materials [6]. Thus, assessing the compressive strength alongside the antibacterial effects of modified GIC is of significant importance.

There have been various reported endeavours to enhance the antibacterial capabilities of GICs by combining them with chlorhexidine hydrochloride, cetylpyridinium chloride, cetrimide, and benzalkonium chloride [7]. According to the literature, only chlorhexidine was widely incorporated into GIC, with all studies showing increased antibacterial activity in vitro [8], but it was not marketed due to chemical agents that can act on the cells of the pulp or the gingiva; hence, this study aimed to modify it with the bioactive component. The use of natural and herbal materials in dentistry is growing in popularity. The Salvadora persica tree, which is frequently used to make miswaks, is one of the most widely utilized materials. East Asia and West Africa are major distribution areas for S. persica. The term "Miswak" refers to a group of wooden sticks originating from diverse plant sources. Extracts from some of these plants have been utilized in the production of mouthwash and toothpaste [9]. S. persica extract demonstrated substantial antibacterial effectiveness against various oral pathogens, which encompassed Candida albicans, Streptococcus mutans, Aggregatibacter actinomycetemcomitans, Lactobacillus acidophilus, Actinomyces naeslundii, and Porphyromonas gingivalis [10]. In the realm of oral health, S. persica is known for its antibacterial, antifungal, anticariogenic, and antiplaque properties [11,12]. Miswak contains fluoride, phosphate, calcium and similar minerals found in the hydroxyapatite crystal of teeth [13]. This suggests its potential to aid in dental caries restoration; hence, this study was designed to modify GIC with Miswak extract and to assess both the antibacterial effectiveness and physical characteristics of Miswak-modified GIC.

Materials and methods

Extract preparation

Miswak sticks were procured from Annai Aravindh Herbals Pvt Ltd., Chennai, India. After undergoing a five-day drying process, the Miswak sticks were utilized to prepare a mixture in a beaker, combining 100 mL of distilled water with 6 g of finely chopped Miswak sticks. This mixture was heated using a heating mantle, bringing it to a boil and maintaining a temperature between 60 and 70 degrees Celsius for a duration of 15 minutes. After filtration through Whatman No. 1 filter paper (Whatman Plc, Maidstone, UK), 80 ml of filtrate was collected in a separate Erlenmeyer flask, and this filtered extract was subsequently concentrated to a volume of 5 ml.

Specimen preparation

Type II GIC (GC Corporation) was utilized in this research study. Groups I, II, and III represent Miswak-modified GIC groups. In these groups, Miswak-modified GIC specimens were created in three different concentration ratios characterized by a powder GIC: Extract: Liquid GIC with Group I (2:1:1), Group II (3:1:2) and Group III (3:2:1). Group IV serves as the control group without any modification, employing conventional GIC. First, the conventional GIC components were mixed, and then the plant extract was added as per the groups. The resulting cement was placed in 6 mm-diameter, 2 mm thick cylindrical moulds, and samples were transferred to cylindrical wells. After application, disc-shaped samples were removed, measured, and recorded. Each group comprised 12 samples, six for S. mutans testing and the remaining six for Lactobacillus. Bacterial resistance was evaluated against S. mutans and Lactobacillus strains. Compressive strength, as per ISO 9917-1:2007 (4.0 mm diameter, 6.0 mm height), cylindrical moulds were prepared with 12 samples in each group. After an hour, samples were soaked in deionized water for 24 hours before testing.

Preparation of bacterial species and inoculation

S. mutans and L. acidophilus strains were acquired from the Department of Microbiology. After obtaining pure cultures, facultative strains were cultivated on Mueller-Hinton Agar (MHA), then subculture was separately introduced into tubes with 5 mL of sterile MHA broth. These tubes were incubated at 37°C for 24 hours, and the resulting suspension was subsequently adjusted to a 0.5 McFarland standard.

Minimal inhibitory concentration (MIC) assay

To evaluate the antimicrobial effectiveness of both modified and unmodified GIC, a total of 48 specimens, involving 12 samples per group, were used, with each well containing 200 µl of sterilized MHA broth. Then, 50 µL of bacterial suspensions at a concentration of 5 x 10^5 CFU/ml were added to the 24 wells (S. mutans) and the remaining for L. acidophilus. As per the groups, modified specimens containing different GIC concentrations (2:1:1), (3:1:2), and (3:2:1) and unmodified specimens were added (Figure 1).

Figure 1. MIC assay in ELISA 96-well plate.

Figure 1

A - Streptococcus mutans, B - Lactobacillus

Incubation was carried out under suitable conditions for varying time intervals (1h, 2h, 3h, 4h). The percentage of deceased cells was measured at 540 nm using an ELISA reader during specific time intervals.

Assessment of compressive strength

The diameter of each sample was assessed using a digital micrometre before placing them vertically in a universal testing machine (Instron, ElectroPuls®, Bangalore, IND). At a crosshead speed of 0.5 mm/min, a compression load was applied to the specimen's long axes until fracture, and readings were recorded.

Statistical evaluation

The data were input into Microsoft Excel (Microsoft® Corp., Redmond, WA) and analyzed using the Statistical Package for the Social Sciences (IBM SPSS Statistics for Windows, IBM Corp., Version 24.0, Armonk, NY) software. Descriptive analysis and repeated measures of analysis of variance (ANOVA) were performed to calculate the mean MIC values, comparing all the groups based on several time intervals. Tukey's post hoc test was assessed for pairwise comparison between groups. Compressive strength was assessed with repeated measures ANOVA to compare the groups, followed by Tukey's post hoc test (P < 0.05, 95% confidence) for pairwise comparison.

Results

Antimicrobial efficacy against S. mutans

Repeated measures of ANOVA tested modified and unmodified GIC's antibacterial activity against S. mutans. Group I, Group II, and Group III exhibited superior performance and statistically significant results compared to Group IV (control) (Figure 2). Also, Tukey's honestly significant difference (HSD) pairwise comparison test showed a significant difference between Group IV and the other three groups (Table 1).

Table 1. Pairwise comparison of antimicrobial efficacy on Streptococcus mutans between four groups.

*P value was significant at 0.05, P value was derived from multiple comparisons of Tukey's honestly significant difference (HSD) test.

Pairwise comparison Mean difference 95% CI P-value
Lower Upper
Group I vs Group II 0.2983 0.027 0.032 0.001*
Group I vs Group III 0.046 0.044 0.049 0.001*
Group I vs Group IV 0.241 0.239 0.244 0.001*
Group II vs Group III 0.169 0.014 0.019 0.001*
Group II vs Group IV 0.271 0.269 0.273 0.001*
Group III vs Group IV 0.288 0.286 0.290 0.001*

Figure 2. Antimicrobial efficacy on Streptococcus mutans between four groups.

Figure 2

MIC: minimal inhibitory concentration

Antimicrobial efficacy against Lactobacillus

For Lactobacillus, a repeated measure of ANOVA demonstrated that the modified groups exhibited notable antimicrobial activity, displaying superior performance compared to the control group (Figure 3). Pairwise comparisons for Lactobacillus revealed a significant difference (p<0.05) between Group IV and the other groups (Table 2), highlighting the pronounced antibacterial activity of Miswak-modified GIC over conventional GIC.

Table 2. Pairwise comparison of antimicrobial efficacy on Lactobacillus between four groups.

*P value was significant at 0.05, P value was derived from multiple comparisons of Tukey's honestly significant difference (HSD) test.

Pairwise comparison Mean difference 95% Confidence interval P-value
Lower Upper
Group I vs Group II 0.030 0.029 0.031 0.001*
Group I vs Group III 0.146 0.144 0.147 0.001*
Group I vs Group IV 0.188 0.186 0.189 0.001*
Group II vs Group III 0.176 0.175 0.177 0.001*
Group II vs Group IV 0.157 0.156 0.158 0.001*
Group III vs Group IV 0.334 0.332 0.335 0.001*

Figure 3. Antimicrobial efficacy on Lactobacillus between four groups.

Figure 3

MIC: minimal inhibitory concentration

Compressive strength

The compression load was applied to the specimens, and values were recorded. A one-way ANOVA showed a statistically significant difference between all groups with a p-value of 0.001 (Table 3). The pairwise comparison revealed Group II and Group III differed significantly from Group IV, with Group IV (control) showing better performance in compressive strength; however, there was no significant difference between Group I and Group IV (control), indicating similar performance of these groups with a p value of 0.995 (p > 0.05) (Table 4).

Table 3. Comparison between groups for evaluation of compressive strength.

*Significant at 0.05, P value was derived by one-way analysis of variance (ANOVA).

Group n Mean ± SD 95% CI P value
Lower Upper
Group I 12 62.51±5.54 58.99 66.03 0.001*
Group II 12 41.49±3.6 39.20 43.78
Group III 12 15.23±4.96 12.07 18.38
Group IV 12 62.69±2.58 60.44 63.73

Table 4. Pairwise comparison for evaluation of compressive strength.

*significant difference at p<0.05, P value was derived from Tukey Post hoc test.

Pairwise comparison Mean difference 95% CI P-value
Lower Upper
Group I vs Group II 21.025 16.30 25.74 0.001*
Group I vs Group III 47.284 42.56 52.00 0.001*
Group I vs Group IV 0.425 4.29 5.14 0.995
Group II vs Group III 26.258 21.53 30.97 0.001*
Group II vs Group IV 20.600 15.87 25.32 0.001*
Group III vs Group IV 46.85 42.13 51.57 0.001*

Discussion

Although dental caries treatments do not always completely eliminate all microorganisms, some remain in residual tissue. When restorations lack effective hermetic seals, the continued presence of cariogenic bacteria can result in recurrent caries and, consequently, the failure of the restoration [14]. To address this challenge, one potential solution is the adoption of dental materials that exhibit properties capable of inhibiting and eradicating bacteria, both bacteriostatic and bactericidal in nature. Introduced by Wilson and Kent in 1972, conventional GICs are tooth-coloured, chemically bonded materials that are inherently anti-caries and contain fluoride, a widely used compound in dentistry. It has a therapeutic effect through its release properties. The ability of GICs to deliver fluoride continuously over an extended period of time offers anti-caries potential that indicates a reduction in caries adjacent to the restoration [15], but again, it cannot inhibit a broad spectrum of microorganisms. Also, cavities treated with ART (atraumatic restorative treatment) may retain infected dentin; thus, GIC proves ineffective in halting the progression of caries, resulting in restoration failure; hence, improving restorative materials to enhance the physical and antibacterial attributes of conventional GIC is necessary. Plant-based phytochemicals are gaining prominence as an alternative to commercial antimicrobial agents. They offer additional benefits, such as traditional medicinal use and cost-effectiveness, while avoiding issues of antibacterial resistance. One example is Miswak, an herbal antimicrobial agent extracted from the S. persica plant.

The current results of the study prove the superior antimicrobial effectiveness of Miswak-modified GIC against S. mutans. These findings are consistent with the work done by Sofrata et al. who reported on S. persica's antibacterial properties against oral microorganisms, including S. mutans and L. acidophilus [16]. An in-vivo study by Kabil NS et al. revealed that the incorporation of Miswak into GIC led to superior antibacterial properties when compared to standard GIC, aligning with our current in vitro findings [17]. Furthermore, a prospective case-control observational study involving Miswak users and non-users revealed a significantly higher prevalence of dental caries among non-users. This study, conducted on 240 schoolchildren over two years, assessed the decayed-missing-filled (DMF) index. The lower incidence of dental caries among Miswak users suggests its potential role in caries prevention [18]. In another study by Lamia Singer et al., it was observed that blending plant extracts like S. persica, Olea europaea, and Ficus carica with GIC resulted in increased antimicrobial activity against S. mutans and Micrococcus luteus, particularly at higher concentrations [19]. The Miswak extract possesses a range of antimicrobial and antifungal attributes attributed to its content of chlorides, trimethylamine, fluoride, silica, saponins, sulfur, flavonoids, and phenols. Its b-sitosterol and m-anisic acid both contribute to its antibacterial activity [19]. A study conducted by El Tatari et al. showed that Salvadoran Persica Extract (SPE) combined with GIC showed promising results in antimicrobial tests, especially against S. mutans [20]. Kalpavriksha AJ et al. found that GIC with 1% CHX and Miswak extract was equally effective against S. mutans and Streptococcus sobrinus [21]. Ashouri et al. study showed that adding lyophilized Miswak to GIC improved its antimicrobial efficacy [22]. One of the studies investigated S. persica capacity to prevent collagen breakdown in demineralized dentin, where an aqueous S. persica extract was applied to demineralized bovine root dentin samples, which under a light microscope revealed that the extract shielded the dentin's collagen matrix from enzymatic degradation by collagenase. This proves a potential role for S. persica in caries prevention [23]. Apart from antimicrobial properties, this current study evaluated the compressive strength of Miswak-modified GIC.

The performance of a material in therapeutic contexts is dependent upon its capacity to bear pressure, stress, and strain. Compressive strength is the primary measure for characterizing dental cement. Hence, it was imperative to evaluate the compressive strength when modifying GIC. The compressive strength test took place after a 24-hour storage period, providing an optimal timeframe for testing its mechanical properties. A study by El Tatar showed that SPE combined with GIC at a concentration of 1% SPE maintained the same level of compressive strength as that of the control group [20], and this is consistent with the present study, where a lower concentration of the extract, i.e., Group I (2:1:1), unaltered the compressive strength. Farret et al. [24], Pavithra et al. [25], and Marti et al. [26] also noted similar results, indicating that the addition of antimicrobial agents at particular concentrations had no impact on the compressive strength characteristics of GIC.

Hence, the clinical significance of GIC infused with Miswak extract is noteworthy, primarily due to its potential effectiveness in combating S. mutans and Lactobacillus, pivotal contributors to caries development, including secondary caries. By incorporating this bacteriostatic agent, it becomes possible to impede caries progression and mitigate the risk of restoration failure. This approach could prove valuable in the treatment of patients with deep caries, early childhood caries, rampant caries, and high caries susceptibility. A limitation of the present study is its omission of intraoral variables such as masticatory stress, moisture levels, and potential discrepancies by operators. Further extensive research is required in regard to the bonding effects of GIC material's long-term stability and performance, which can promote a novel natural bioactive restorative material.

Conclusions

The findings of the present study suggested that a lower concentration of Miswak extract has the potential to enhance antimicrobial properties without compromising the material's strength. Therefore, Miswak containing GIC can be a promising restorative material. Further studies are recommended to investigate setting time, fluoride release, and in vivo behaviour.

The authors have declared that no competing interests exist.

Author Contributions

Concept and design:  Jessy Paulraj, Kamala Devi, Rajeshkumar Shanmugam

Acquisition, analysis, or interpretation of data:  Jessy Paulraj, Kamala Devi, Rajeshkumar Shanmugam, Subhabrata Maiti

Drafting of the manuscript:  Jessy Paulraj, Kamala Devi

Critical review of the manuscript for important intellectual content:  Jessy Paulraj, Kamala Devi, Rajeshkumar Shanmugam, Subhabrata Maiti

Supervision:  Jessy Paulraj, Rajeshkumar Shanmugam, Subhabrata Maiti

Human Ethics

Consent was obtained or waived by all participants in this study

Animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

References

  • 1.Absence of carious lesions at margins of glass-ionomer cement and amalgam restorations: an update of systematic review evidence. Mickenautsch S, Yengopal V. BMC Res Notes. 2011;4:58. doi: 10.1186/1756-0500-4-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Biological activities of glass ionomer cement supplemented with fortilin on human dental pulp stem cells. Sangsuwan P, Tannukit S, Chotigeat W, Kedjarune-Leggat U. J Funct Biomater. 2022;13:132. doi: 10.3390/jfb13030132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Nigel P. Understanding Dental Caries. Springer, Cham; 2016. Understanding dental caries: from pathogenesis to prevention and therapy; pp. 3–9. [Google Scholar]
  • 4.American Academy of Pediatric Dentistry. American Academy of Pediatric Dentistry; 2019. American Academy of Pediatric Dentistry, the Reference Manual of Pediatric Dentistry: Definitions, Oral Health Policies, Recommendations, Endorsements, Resources. [Google Scholar]
  • 5.Param P, Anas H, Achal S, Dhruv P, Shyam P, Priyanka B, Yashwant VP. Surface Modification of Nanoparticles for Targeted Drug Delivery. Springer Cham; 2019. Surface modification of nanoparticles for targeted drug delivery; pp. 19–31. [Google Scholar]
  • 6.Ece Eden. Evidence-Based Caries Prevention. Springer Cham; 2016. Antimicrobials in caries prevention; pp. 71–85. [Google Scholar]
  • 7.Comparison of antifungal activity of 2% chlorhexidine, calcium hydroxide, and nanosilver gels against Candida albicans. Mozayeni MA, Hadian A, Bakhshaei P, Dianat O. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434124/ J Dent (Tehran) 2015;12:109–117. [PMC free article] [PubMed] [Google Scholar]
  • 8.In vitro and in vivo evaluations of glass-ionomer cement containing chlorhexidine for Atraumatic Restorative Treatment. Duque C, Aida KL, Pereira JA, et al. J Appl Oral Sci. 2017;25:541–550. doi: 10.1590/1678-7757-2016-0195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.An in vivo study of the plaque control efficacy of Persica: a commercially available herbal mouthwash containing extracts of Salvadora persica. Khalessi AM, Pack AR, Thomson WM, Tompkins GR. Int Dent J. 2004;54:279–283. doi: 10.1111/j.1875-595x.2004.tb00294.x. [DOI] [PubMed] [Google Scholar]
  • 10.In vitro antimicrobial effects of crude miswak extract on oral pathogens. El Rahman HF, Skaug N, Francis GW. https://www.researchgate.net/publication/284150487_In_vitro_antimicrobial_effects_of_crude_Miswak_extracts_on_oral_pathogens Saudi Dent J. 2002;14:26–32. [Google Scholar]
  • 11.Antibacterial activity of Salvadora persica L. (miswak) extracts against multidrug resistant bacterial clinical isolates. Al-Ayed MS, Asaad AM, Qureshi MA, Attia HG, AlMarrani AH. Evid Based Complement Alternat Med. 2016;2016:7083964. doi: 10.1155/2016/7083964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Effect of mouthwash extracted from Miswak (Salvadora Persica) on periodontal pathogenic bacteria an in-vitro study. Al-Bayaty FH, Abdulla MA, Hassan Md IA, Siti Noraini BR, Saba FH, Hasnah BBS. International Conference on Science and Social Research. 2010:178–181. [Google Scholar]
  • 13.Ion release and enamel remineralizing potential of miswak, propolis and chitosan nano-particles based dental varnishes. Wassel MO, Sherief DI. Pediatr Dent J. 2019;29:1–10. [Google Scholar]
  • 14.Marit SS, Anita A, Wendt KL, Sven P. Pediatric Dentistry: A Clinical Approach. John Wiley & Sons; 2016. Dental caries in children and adolescents; pp. 102–113. [Google Scholar]
  • 15.An initial evaluation of cytotoxicity, genotoxicity and antibacterial effectiveness of a disinfection liquid containing silver nanoparticles alone and combined with a glass-ionomer cement and dentin bonding systems. Porenczuk A, Grzeczkowicz A, Maciejewska I, et al. Adv Clin Exp Med. 2019;28:75–83. doi: 10.17219/acem/76160. [DOI] [PubMed] [Google Scholar]
  • 16.Strong antibacterial effect of miswak against oral microorganisms associated with periodontitis and caries. Sofrata AH, Claesson RL, Lingström PK, Gustafsson AK. J Periodontol. 2008;79:1474–1479. doi: 10.1902/jop.2008.070506. [DOI] [PubMed] [Google Scholar]
  • 17.Effect of the addition of chlorhexidine and miswak extract on the clinical performance and antibacterial properties of conventional glass ionomer: an in vivo study. Kabil NS, Badran AS, Wassel MO. Int J Paediatr Dent. 2017;27:380–387. doi: 10.1111/ipd.12273. [DOI] [PubMed] [Google Scholar]
  • 18.Study of caries prevalence among miswak and non-miswak users: a prospective study. Mustafa M, Al Jeaidi Z, Al Aajam WH, Dafaalla Mohammed KA. https://www.thejcdp.com/doi/pdf/10.5005/jp-journals-10024-1955. Dent Pract. 2016;17:926–929. [PubMed] [Google Scholar]
  • 19.Evaluation of the antimicrobial activity and compressive strength of a dental cement modified using plant extract mixture. Singer L, Bierbaum G, Kehl K, Bourauel C. J Mater Sci Mater Med. 2020;31:116. doi: 10.1007/s10856-020-06455-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Influence of Salvadora persica (miswak) extract on physical and antimicrobial properties of glass ionomer cement. El-Tatari A, de Soet JJ, de Gee AJ, Abou Shelib M, van Amerongen WE. Eur Arch Paediatr Dent. 2011;12:22–25. doi: 10.1007/BF03262774. [DOI] [PubMed] [Google Scholar]
  • 21.Comparative evaluation of antibacterial effect of GIC containing chlorhexidine and miswak on Streptococcus mutans and Streptococcus sobrinus in early childhood caries children: a PCR study. Kalpavriksha AJ, Siddaiah SB, Bilichodmath S, Prabhakara S, Rao HH. Int J Clin Pediatr Dent. 2021;14:229–234. doi: 10.5005/jp-journals-10005-1942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Antimicrobial efficacy of glass ionomer cement in incorporation with biogenic Zingiber officinale capped silver-nanobiotic, chlorhexidine diacetate and lyophilized miswak. Ashour AA, Basha S, Felemban NH, Enan ET, Alyamani AA, Gad El-Rab SM. Molecules. 2022;27:528. doi: 10.3390/molecules27020528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Inhibitory effect of Salvadora persica extract (Miswak) on collagen degradation in demineralized dentin: in vitro study. Khunkar S, Hariri I, Alsayed E, et al. J Dent Sci. 2021;16:208–213. doi: 10.1016/j.jds.2020.05.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Can we add chlorhexidine into glass ionomer cements for band cementation? Farret MM, de Lima EM, Mota EG, Oshima HM, Barth V, de Oliveira SD. Angle Orthod. 2011;81:496–502. doi: 10.2319/090310-518.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Comparative evaluation of antimicrobial activity and compressive strength of conventional and thyme-modified glass ionomer cement. Pavithra AS, Jessy P, Rajeshkumar S, Maiti S. Ann Dent Spec. 2023;11:70–77. [Google Scholar]
  • 26.Effect of chlorhexidine gluconate on porosity and compressive strength of a glass ionomer cement. Marti L, Azevedo ER, Mata MD, Giro Elisa MA, Zuanon Angela CC. Rev Odontol UNESP. 2014;43:236–240. [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES